From: Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
 | StageII (n = 260, 53.1%) | Stage III (n = 230, 46.9%) |  | ||
---|---|---|---|---|---|
Variable | n | (%) | n | (%) | P value |
Age (years) | Â | Â | Â | Â | 0.024 |
< 65 | 85 | 32.7 | 98 | 42.6 | Â |
≥ 65 | 175 | 67.3 | 132 | 57.4 |  |
Sex | Â | Â | Â | Â | 0.959 |
Male | 134 | 51.5 | 118 | 51.3 | Â |
Female | 126 | 48.5 | 112 | 48.7 | Â |
Race | Â | Â | Â | Â | 0.202 |
Caucasian Americans | 165 | 63.5 | 133 | 57.8 | Â |
African Americans | 95 | 36.5 | 97 | 42.2 | Â |
Tumor grade | Â | Â | Â | Â | 0.380 |
Low | 216 | 83.1 | 184 | 80.0 | Â |
High | 44 | 16.9 | 46 | 20.0 | Â |
Tumor location | Â | Â | Â | Â | 0.521 |
Distal | 100 | 38.5 | 95 | 41.3 | Â |
Proximal | 160 | 61.5 | 135 | 58.7 | Â |
Tumor size (cm) | Â | Â | Â | Â | 0.040 |
< 5 | 116 | 44.6 | 124 | 53.9 | Â |
≥ 5 | 144 | 55.4 | 106 | 46.1 |  |
Adjuvant chemotherapy | Â | Â | Â | Â | < 0.0001 |
No | 237 | 91.2 | 180 | 78.3 | Â |
Yes | 23 | 8.8 | 50 | 21.7 | Â |
Status | Â | Â | Â | Â | < 0.0001 |
Alive | 89 | 34.2 | 59 | 25.6 | Â |
Death due to colon cancer | 77 | 29.6 | 123 | 53.5 | Â |
Death due to other causes | 94 | 36.2 | 48 | 20.9 | Â |
Recurrence (years) | Â | Â | Â | Â | 0.048 |
No | 209 | 80.4 | 163 | 70.9 | Â |
≤ 2 | 35 | 13.5 | 47 | 20.4 |  |
> 2 | 16 | 6.1 | 20 | 8.7 | Â |
Number of LNs harvested | Â | Â | Â | Â | 0.615 |
1-6 | 55 | 21.2 | 38 | 16.5 | Â |
7-11 | 63 | 24.2 | 57 | 24.8 | Â |
12-19 | 75 | 28.8 | 73 | 31.7 | Â |
≥ 20 | 67 | 25.8 | 62 | 27.0 |  |